Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Oct;16(4):510-3.
doi: 10.1128/AAC.16.4.510.

Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics

Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics

V P Syriopoulou et al. Antimicrob Agents Chemother. 1979 Oct.

Abstract

The current prevalence of ampicillin-resistant Haemophilus influenzae b meningitis requires accurate knowledge of susceptibility to alternative antibiotics. One variable affecting susceptibility is inoculum size. We studied the susceptibility of 200 clinical isolates of H. influenzae b to ampicillin, carbenicillin, and cefamandole at inocula of 10(5) and 10(7) CFU by two techniques. Fifty ampicillin-susceptible and fifty ampicillin-resistant strains were tested for susceptibility to ampicillin by broth dilution while 100 of each were tested by agar dilution. An inoculum effect was found, being greatest with the ampicillin-resistant strains. The range of minimal inhibitory concentrations for the resistant strains was 25 to 800 microgram of ampicillin per ml at an inoculum of 10(5) and 2,000 to less than 6,000 microgram of ampicillin at 10(7); 1.0 to 150 microgram of carbenicillin per ml at 10(5) and 6.2 to 2,000 microgram of carbenicillin per ml at 10(7); 0.4 to 2.0 microgram of cefamandole at 10(5) and 1.0 to 125 microgram/ml at 10(7). Because of this inoculum effect, we would not recommend the use of carbenicillin or cefamandole for therapy of ampicillin-resistant H. influenzae meningitis.

PubMed Disclaimer

References

    1. J Clin Invest. 1947 May;26(3):379-93 - PubMed
    1. Am J Med Sci. 1960 Jan;239:33-40 - PubMed
    1. Antimicrob Agents Chemother. 1978 Jul;14(1):154-6 - PubMed
    1. J Infect Dis. 1978 May;137 Suppl:S180-S189 - PubMed
    1. Pediatrics. 1976 Sep;58(3):382-7 - PubMed

MeSH terms

LinkOut - more resources